Catalyst Wire Dossier Catalyst Wire Dossier

Triumeq

dolutegravir/abacavir/lamivudine · ViiV Healthcare
Drug timelines are a Plus or Pro feature.

31 regulatory and trial events tracked for Triumeq, covering 2014-08-22 to 2025-10-28. Get the full timeline:

Most recent: FDA Approved: TRIUMEQ — Supplemental Application (ViiV Healthcare Company)

See pricing